跳到正文

Sands Capital Alternatives, LLC 13F 持仓 · 2026年Q2

Sands Capital Alternatives 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 24 只证券,申报市值合计 6.14 亿美元。前几大持仓:ALMR(18.68%)、NU(15.45%)、KVYO(9.67%)。本季前 25 大持仓中:新建仓 3 只、增持 10 只、减持 2 只。

排名代码公司市值占组合股数变动
1ALMRALAMAR BIOSCIENCES INC$114.6M18.68%4.2M新建仓
2NUNU HLDGS LTD$94.8M15.45%7.1M增持
3KVYOKLAVIYO INC$59.3M9.67%3.9M增持
4BBNXBETA BIONICS INC$58.1M9.47%3.7M持平
5SGPSPYGLASS PHARMA INC$55.7M9.07%2.5M持平
6IKTINHIBIKASE THERAPEUTICS INC$26.4M4.31%13.0M持平
7DASHDOORDASH INC$23.5M3.84%127,562增持
8CPNGCOUPANG INC$23.1M3.76%1.3M增持
9DDOGDATADOG INC$21.1M3.43%80,851减持
10BIOABIOAGE LABS INC$19.3M3.14%786,353持平
11TXG10X GENOMICS INC$18.5M3.01%481,770持平
12IOTSAMSARA INC$16.7M2.73%515,658减持
13ODTXODYSSEY THERAPEUTICS INC$16.4M2.67%875,000新建仓
14TOSTTOAST INC$10.2M1.65%364,879增持
15ABOSACUMEN PHARMACEUTICALS INC$9.9M1.62%3.7M持平
16TTANSERVICETITAN INC$7.7M1.25%108,545增持
17CBRSCEREBRAS SYSTEMS INC$7.3M1.18%32,825新建仓
18SNOWSNOWFLAKE INC$6.2M1.02%24,498增持
19MNDYMONDAY COM LTD$5.9M0.97%81,982增持
20TARSTARSUS PHARMACEUTICALS INC$5.3M0.87%85,000持平
21TSHATAYSHA GENE THERAPIES INC$4.9M0.80%724,873持平
22CADLCANDEL THERAPEUTICS INC$4.2M0.68%405,837持平
23ACRVACRIVON THERAPEUTICS INC$4.1M0.66%2.3M增持
24FIGFIGMA INC$400,9650.07%22,165增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR